 |
FDA Approval Activities for this Drug
Priftin (rifapentine),Rx Hoechst Marion Roussel NDA 21-024 6/22/98 7/15/98 7/15/98 12/11/98
Priftin Indication: Pulmonary tuberculosis
Priftin (rifapentine) Tablets, 150 mg, Aventis NDA 21-024/SE7-005 10/20/00 12/11/01
Priftin Indication: treatment of pulmonary tuberculosis
For the most up-to-date approval information, please locate this API using the drug index. For industry specific content, please visit USActives.com.
|